Another Legislative Attempt to Revive Gene Patenting
Bill of Health
AUGUST 4, 2022
In its unanimous 2013 decision in Association for Molecular Pathology v. In late 2013, Myriad sued competing BRCA test vendors under patents that it believed were not affected by the Court’s decision. Myriad Genetics (569 U.S. 576) the U.S. Prior Efforts to Reverse Myriad.
Let's personalize your content